Search results for "slas europe 2018"
Selected Filters:
Helicobacter pylori IgA ELISA
DRG International Inc.High Quality Assays with Reproducible and Reliable Results
Mycoplasma pneumoniae IgG ELISA
DRG International Inc.High Quality Assays with Reproducible and Reliable Results
Drug development: Improving analytical method performance through quality risk management and a design of experiments approach
Join our webinar on Wednesday, September 4, for an overview of Quality by Design approaches to analytical method development
How to easily ID unknown particles in drug formulations
Join this upcoming webinar to learn a simplified method for identifying unknown particles with Raman spectroscopy and LIBS
Analyzing Volatile Organic Compounds with Direct Mass Spectrometry
To improve the speed of VOC analysis in your lab, sign up now to our expert webinar on March 21
Improving Detection and Treatment of Whooping Cough
DiaSorin Molecular receives FDA clearance for Bordetella test
Developing a New Therapeutic for Tuberculosis
Gyros Protein Technologies Introduces Multi-Species Kit for Toxicokinetic Studies
Gyrolab Generic TK Kit for early-stage biotherapeutic development
Free Webinar: Practical Tips to Improve Reproducibility When Using Biological Buffers
Experts share important considerations that can help to improve reproducibility of preclinical research
New Editions of Newsletters from Rigaku Feature Latest Materials Science and Life Sciences News
Latest editions of The Bridge newsletter from Rigaku and Crystallography Times from Rigaku Oxford Diffraction are available from the Rigaku global website
Screening for Pesticides in Human Breast Milk
Learn about research using GC-MS/MS technology to analyze pesticide residues in breast milk
FERA Takes Analysis from the Laboratory to the Benchtop
SelectScience® spoke to Dr James Donarski, The Food and Environment Research Agency (FERA), at RAFA
Extend the Capabilities of Your TEM with a DENSsolutions In Situ TEM System
AXT are to distribute the complete range of DENSsolutions in situ TEM systems in Australia and New Zealand.
DiaSorin Launches the two Fastest Molecular Diagnostic Tests in the World to Detect Fulminant Leukemias
Early identification of the disease will allow specific and extremely effective therapies for the treatment of patients